Exclusive Articles 1 min.Read Healthcare Disruption – Will Ola, Swiggy, Pharmaeasy, and Hospitals Converge to Deliver Health Care on Call at Your Doorstep? By Anup Soans May 26, 2022 FacebookTwitterPinterestWhatsApp Swiggy is working on a marketplace to onboard local stores and direct-to-consumer (D2C) brands and the pilot is already underway. The platform is called Minis. There are select brands and merchants with whom Swiggy is testing this out. Free Membership Required You must be a Free member to access this content. Join Now Already a member? Log in here Hot this week Healthcare C-Suite Movements Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited. October 2, 2026 0 With over three decades of experience in the pharmaceutical... MedicinMan Market Intelligence The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist? September 29, 2026 0 India’s anaemia challenge is not simply about access to... MedicinMan Market Intelligence 10 Years of Pharma M&A — Who’s Really Benefited? September 27, 2026 0 Pharmaceutical M&A is usually discussed in the language of... Ethics in Healthcare What’s Killing Patients? Cancer or Rigged Drug Prices? September 24, 2026 0 The disease is real. So is the markup. Confusing... MedicinMan Market Intelligence A Tale of Two Cities: Peptides and Prescriptions September 21, 2026 0 What our health choices reveal about education, access and... Topics Healthcare C-Suite Movements Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited. 0 With over three decades of experience in the pharmaceutical... MedicinMan Market Intelligence The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist? 0 India’s anaemia challenge is not simply about access to... MedicinMan Market Intelligence 10 Years of Pharma M&A — Who’s Really Benefited? 0 Pharmaceutical M&A is usually discussed in the language of... Ethics in Healthcare What’s Killing Patients? Cancer or Rigged Drug Prices? 0 The disease is real. So is the markup. Confusing... MedicinMan Market Intelligence A Tale of Two Cities: Peptides and Prescriptions 0 What our health choices reveal about education, access and... MedicinMan Market Intelligence Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right? 0 MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam... MedicinMan Market Intelligence The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics 0 Private equity does not pay a billion-dollar multiple simply... MedicinMan Pharma Pulse Medical Reps—Lessons From The West: The Old Model is Dead 0 The Core Conclusion The Western pharma industry is not simply... Related Articles Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology? Exclusive Articles August 21, 2026 The Anatomy of a Miscalculation: Why Maharashtra’s Homeopathic Prescription Policy Defies Global Medical Standards Exclusive Articles August 10, 2026 What ChrysCapital’s Takeover Of Novartis India Really Means Exclusive Articles July 30, 2026 Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare AI in Healthcare July 17, 2026 Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman Exclusive Articles June 8, 2026 Previous articleHuman Library – Reading People Through Their Life’s ExperiencesNext articleDigital in Pharma and RoI – What and How to Measure Metrics that Matter